tirzepatide vs semaglutide side effects vs. Semaglutide: Which Has Fewer Effects? Weighing up the Risks: GI

During a median follow-up of 5.4 (IQR 5.15.9) years, patients with a 1.5 mg/week subcutaneous injection of dulaglutide showed a lower incidence rate of the primary composite outcome including non-fatal myocardial infarction, non-fatal stroke, or death from cardiovascular causes ( HR = 0.88, 95% CI 0.790.99, P = 0.026) [62]

Access barriers Getting a prescription for semaglutide requires a healthcare provider visit, meeting specific diagnostic criteria, insurance authorization (often denied), and ongoing medical supervision

The framework below outlines key considerations for patients considering or already using GLP-1 medications after gallbladder removal

doi:10.1111/dom.13851 Jendle J, Grunberger G, Blevins T, et al